1. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48(1):6–29
2. Pauler DK, Menon U, McIntosh M, Symecko HL, Skates SJ, Jacobs IJ (2001) Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev 10(5):489–493
3. Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K (2005) New tumor markers: CA125 and beyond. Int J Gynecol Cancer 15(Suppl 3):274–281
4. Bandera CA, Ye B, Mok SC (2003) New technologies for the identification of markers for early detection of ovarian cancer. Curr Opin Obstet Gynecol 15(1):51–55
5. Rosen DG, Wang L, Atkinson JN, Yu Y, Lu KH, Diamandis EP, Hellstrom I, Mok SC, Liu J, Bast RC Jr (2005) Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol 99(2):267–277